Lund-based eHealth startup PainDrainer is getting much attention from various investors. One of them is the former KappAhl-top .

PrainDrainer has developed cloud-based applications for self-management of chronic pain, using multilevel Artificial Intelligent Systems. According to themselves, the product is the first drug free, self-management tool identification of each patient’s pain triggers and pain protectors, allowing the patient to increase the quality of life, based on the personal analysis and prognosis by AI. Although only one year has passed since they founded the company, they are already at the stage to start clinical studies.

“Hopefully we can launch to consumers already next year. It’s the fastest project I’ve been involved in”, says Carl Borrebaeck to Rapidus.

PainDrainer was founded in 2018 led by Professor Carl Borrebaeck, together with IT entrepreneur Göran Barkfors and researcher Maria Klement. Göran is an experienced entrepreneur who has previously founded Nasdaq-listed Immunovia, Alligator Bioscience and Senzagen among others. The startup has also an advisory board consisting of clinical pain management expert Christer Carlsson and AI specialist Mattias Ohlsson.

They have raised € 600.000 (SEK 6.7 millions) from nine investors including profile investor Christian W Jansson. The money will be invested in hiring staff to start up the business seriously after the clinical trials, and invest in digital marketing. In addition, for the further expansion, the company will move to new premises in Medicon Village in September.

“So far we have only been a bunch of enthusiasts who have worked on this, but now we are going to get started really”, says Carl